Aligos Therapeutics, Inc. (ALGS) Earnings
|
Expand Research on ALGS
| Next EPS Date | N/A | EPS Growth Rate | +85.4% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -426.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +30.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/5/26 | Q425 | -$1.91 | $0.00 | -$1.91 | N/A | N/A | N/A |  | | Details | |
11/6/25  |
Q325 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/25 | Q225 | -$1.53 | $0.00 | -$1.53 | N/A | N/A | N/A | | | Details | |
| 3/10/25 | Q424 | -$13.08 | $0.00 | -$13.08 | N/A | N/A | N/A | | | Details | |
| 11/6/24 | Q324 | -$3.07 | -$0.17 | -$2.90 | N/A | N/A | N/A | | | Details | |
| 8/6/24 | Q224 | $0.03 | -$0.16 | +$0.19 | N/A | N/A | N/A | | | Details | |
| 8/1/24 | Q224 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/24 |
Q124 | N/A | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A |
